SFX by Ex Libris Inc.

Title:	Extra-helical binding site of a glucagon receptor antagonist
Source:	Nature [0028-0836] Jazayeri, A yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Xia, Y. "A tunable topological insulator in the spin helical Dirac transport regime." Nature 460.7259 (2009): 1101-1105.
description	2.	"A euglycaemic clamp pilot study assessing the effects of the glucagon receptor antagonist LY2409021 on 24-hour insulin requirement in patients with type 1 diabetes mellitus." Diabetologia. 56.
description	3.	Zhang, H. "Structure of the full-length glucagon class B G-protein-coupled receptor." Nature 546.7657 (2017): 259-264.
description	4.	Burcelin, R. "In vivo and in vitro regulation of hepatic glucagon receptor mRNA concentration by glucose metabolism." The Journal of biological chemistry 273.14 (1998): 8088-93.
description	5.	DeLucca, George V. "Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists." Journal of medicinal chemistry 45.17 (2002): 3794-1208.
description	6.	Roushan, J. "Topological surface states protected from backscattering by chiral spin texture." Nature 460.7259 (2009): 1106-9.
description	7.	Hsieh, D. "A topological Dirac insulator in a quantum spin Hall phase." Nature 452.7190 (2008): 970-4.
description	8.	Xia, Y. "Observation of a large-gap topological-insulator class with a single Dirac cone on the surface." Nature Physics 5.6 (2009): 398-402.
description	9.	Wang, Y. "TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS." Proceedings of the National Academy of Sciences of the United States of America 113.7 (2016).
description	10.	"Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes." Expert opinion on investigational drugs 26.12: 1373-1389.
description	11.	Lu, J. "How to make insulin-producing pancreatic β cells for diabetes treatment." Science China. Life Sciences 60.3 (2016): 239-248.
description	12.	Hua, T. "Crystal Structure of the Human Cannabinoid Receptor CB1." Cell 167.3 (2016): 750-4294967295.
description	13.	Zhao, L. "Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors." Journal of biological chemistry 291.29 (2016): 15119-15130.
description	14.	Naziroglu, M. "Modulation of Diabetes-Induced Oxidative Stress, Apoptosis, and Ca2+ Entry Through TRPM2 and TRPV1 Channels in Dorsal Root Ganglion and Hippocampus of Diabetic Rats by Melatonin and Selenium." Molecular Neurobiology 54.3 (2016): 2345-2360.
description	15.	Charron, Maureen J. "Lack of glucagon receptor signaling and its implications beyond glucose homeostasis." Journal of Endocrinology 224.3 (2015): -30.
description	16.	Mu, Eric R. "Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist." PLoS ONE 7.11 (2012).
description	17.	Shinno, H. "Biochemical functions of adult rat hepatocytes in primary culture." Annals of the New York Academy of Sciences 349 (1980): 77-84.
description	18.	Arey, Brian J J. "A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo." Endocrinology 146.4 (2005): 2015-22.
description	19.	Hayes, Martin E. "Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3." Bioorganic & medicinal chemistry letters 18.5 (2008): 1573-1576.
description	20.	Fleischer, Jason W. "Observation of two-dimensional discrete solitons in optically induced nonlinear photonic lattices." Nature 422.6928 (2003): 147-150.